America's health insurers have committed to covering routine vaccines through 2027, even as President Donald Trump signed an executive order last week directing federal agencies to reduce the number of recommended childhood immunizations, deepening a stand-off between the insurance industry and the administration over vaccine policy.
AHIP, the national trade organization representing insurers that collectively cover more than 200 million Americans, announced at the end of May that its members will continue covering routine vaccines through 2027, extending a similar commitment made for 2026.
According to a report from The Guardian, the decision came after a federal judge paused controversial changes to the Advisory Committee on Immunization Practices (ACIP), the body whose recommendations legally require insurers to provide vaccine coverage without cost-sharing.
"Insurance companies are clearly choosing to cover vaccines because they know that they are safe and effective," said Elizabeth Jacobs (pictured), an epidemiology professor at the University of Arizona and founding member of Defend Public Health. "They've run the numbers and they know that it will cost them a heck of a lot more to treat kids with measles who are hospitalized than it is to pay for vaccines."
Under the Affordable Care Act, coverage requirements for all major payers are currently linked to ACIP and CDC vaccine recommendations. A narrowing or removal of a recommendation would mean most insurers are no longer legally required to provide no-cost coverage.
AHIP's pledge to maintain coverage voluntarily therefore represents a decision to go beyond the minimum legal obligation at a time when that minimum is itself in dispute, the report said.
Private insurers have historically tied pediatric vaccine coverage directly to ACIP recommendations. Under the ACA, vaccines with an ACIP "A" or "B" rating must be covered without cost-sharing. Remove the recommendation, and the legal obligation to cover disappears with it. One expert warned in the American Journal of Managed Care that current stability may not hold: "A year from now, I think that's going to be quite different."
In June 2025, the Supreme Court ruled that the ACA's preventive services mandate is constitutional, upholding the use of USPSTF recommendations as guidance for coverage requirements, a ruling that reinforced the legal framework AHIP's members are now voluntarily exceeding.
The insurers' commitment comes as the US faces a serious resurgence of vaccine-preventable diseases with direct financial consequences for payers. As of May 28, 2026, 1,983 confirmed measles cases had been reported across 40 US jurisdictions, with 93% of cases outbreak-associated. For the full year of 2025, the US confirmed 2,288 cases, more than any year since 1991, including three deaths, putting the country's measles elimination status at risk of being revoked.
The financial stakes for payers are substantial and rising.
A peer-reviewed study published in the Proceedings of the National Academy of Sciences estimated that measles imposed a cost of $244.2 million nationwide in 2025, with an average cost per case of $104,629. Researchers modeled a scenario in which MMR coverage among young children declined by 1% per year, projecting that costs could total $7.77 billion over a five-year period.
Separate analysis from the Common Health Coalition found that even a 1% decrease in the childhood MMR vaccination rate could cause 17,000 measles cases, 4,000 hospitalizations and 36 preventable deaths each year.
Trump signed the executive order on May 29, directing the CDC and ACIP to review and potentially update the childhood immunization schedule, backing an HHS assessment calling for fewer recommended childhood vaccines, the report said. The number of recommended childhood shots had already been reduced from 17 to 11 in January 2026, the most significant reshaping of the vaccine schedule since Trump took office. Those changes were subsequently paused by a federal judge following a lawsuit from the American Academy of Pediatrics.
Richard Hughes, one of the lawyers representing the AAP, said any changes resembling those made in January would violate the judge's existing order, and that the executive order "may signal that the administration is planning to convene the committee soon." He noted that Trump's own pollsters have cautioned the White House that anti-vaccine rhetoric is "politically risky" ahead of the November midterm elections.
For Jacobs, the insurers' stance amounts to an important counterweight. "It still remains deeply problematic that representatives of the US government continue to undermine vaccines," she said. "It just continues this confusion and causes absolutely unnecessary fear among parents."
